Trials / Not Yet Recruiting
Not Yet RecruitingNCT07460882
The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 607 (estimated)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this pre-post study is to assess the risk of hyperkalemia in adults with hypertension on medication in Bangladesh. The main questions it aims to answer are: Is the risk of hyperkalemia after the initiation of Low Sodium Salt Substitute (LSSS) in people on antihypertensive medication (especially RASi) large enough to be concerned about its broad use in this population? Does initiation of LSSS correct hypokalemia in people on antihypertensive medication (especially RASi) with low serum potassium levels? Participants will be asked to reduce overall salt intake and to use LSSS on every occasion where regular salt would normally be used, including as cooking salt.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Low-sodium salt substitute | The low sodium salt substitute contains 25% potassium chloride (KCl range; 20%-35%) |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-03-31
- Completion
- 2027-09-30
- First posted
- 2026-03-10
- Last updated
- 2026-04-13
Source: ClinicalTrials.gov record NCT07460882. Inclusion in this directory is not an endorsement.